JHS Svendgaard Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 254.46 million compared to INR 209.14 million a year ago. Revenue was INR 271.19 million compared to INR 236.53 million a year ago. Net loss was INR 15.28 million compared to net income of INR 2.65 million a year ago. Basic loss per share from continuing operations was INR 0.24 compared to basic earnings per share from continuing operations of INR 0.04 a year ago. Diluted loss per share from continuing operations was INR 0.24 compared to diluted earnings per share from continuing operations of INR 0.04 a year ago.
For the nine months, sales was INR 708.08 million compared to INR 671.38 million a year ago. Revenue was INR 773.95 million compared to INR 741.48 million a year ago. Net loss was INR 55.9 million compared to net income of INR 3.06 million a year ago. Basic loss per share from continuing operations was INR 0.86 compared to basic earnings per share from continuing operations of INR 0.05 a year ago. Diluted loss per share from continuing operations was INR 0.86 compared to diluted earnings per share from continuing operations of INR 0.05 a year ago.